Juliya Nikolaevna Vinogradova

Juliya Nikolaevna Vinogradova

Auto-generated profile, based on publicly available information

Juliya Nikolaevna Vinogradova

Russian Scientific Centre of Radiology and Surgical Technologies named after Academician A.M. Granov of the Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
YVYu. N. Vinogradova
Yu. N. Vinogradova
NIN. V. Ilyin
N. V. Ilyin
MTM. S. Tlostanova
M. S. Tlostanova
AIA. A. Ivanova
A. A. Ivanova
Visual analysis of positron emission tomography/computed tomography (PET/CT) scans and semiquantitative parameter of glucose’s standardized uptake value are used in PET/CT with18F-fluorodeoxyglucose (18F-FDG). Recently some volumetric parameters, which can evaluate metabolic tumor volume for patients with lymphomas and total lesion glycolysis in the tumor sites are established. In our study this problem was analyzed for different types of lymphomas considering clinical importance of these rates and their bond to known factors of international prognostic index.

11 November 2024 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
MZMaria I. Zelianina
Maria I. Zelianina
YVYulia N. Vinogradova
Yulia N. Vinogradova
DZDenis V. Zaslavskiy
Denis V. Zaslavskiy
EGElina V. Gilvanova
Elina V. Gilvanova
NINikolay V. Ilyin
Nikolay V. Ilyin
ИВИльин Николай Васильевич
Ильин Николай Васильевич
Background. One of the main adverse events that significantly reduce the quality of life of patients and limit the total focal dose is radiation-induced skin reactions (RISR). Their timely diagnosis, prevention, and treatment remain urgent tasks of modern radiotherapy. Aim. To improve the effectiveness of total skin irradiation (TSI) in patients with primary skin lymphomas by reducing the clinical manifestations of RISR by using additional therapy with a hydrogel containing active components with vasoprotective and anti-inflammatory action. Materials and methods. A comparative randomized prospective study was conducted, including data from 52 patients who received electron TSI by conventional fractionation at a total focal dose of 14 to 30 Gy for primary cutaneous lymphomas at the Granov Russian Research Center of Radiology and Surgical Technologies from September 2021 to January 2024. Before the first TSI session, during treatment and 2 weeks after the end of radiation therapy, all patients underwent assessment for RISR, quantitative assessment of various degrees of severity of radiodermatitis using instrumental methods and assessment scales; for the observation group, a therapeutic regimen for the prevention and treatment of RISR was used, including a hydrogel with troxerutin (2%) and trolamine (0.07%), and in the control group, basic skin care using moisturizers. Results. Analysis of the physiological parameters of the skin showed statistically significant differences between the study groups: patients of the study group (group I; 30 subjects receiving the above-mentioned therapeutic regimen) compared with the control group (group II; 28 subjects who did not receive specific treatment for radiodermatitis) reported significantly lower rates of erythema (386±12.3 and 572±14.4; p=0.005), transepidermal water loss (25±0.3 and 38±0.4 g/m2/h; p0.001) and a decrease in peak endothelial-dependent vasodilation of microvasculature and blood flow in the skin. A lower proportion of severe radiodermatitis (86.3 and 73.3%; p0.05) and a statistically significant difference in the subjective quality of life scores by the 29-point Skindex-29 scale by an average of 22.2% were also found. Conclusion. A comparative analysis of the quantitative indicators of radiodermatitis in the study group and the control group showed that the topical application of the hydrocolloid gel containing troxerutin and trolamine reduces the clinical manifestations of RISR concerning objectively measured physiological parameters of the skin and blood flow parameters of the microvasculature measured by high-frequency ultrasound, thus improving the quality of life of patients during and after the course of radiation therapy.

26 November 2021 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
YVYu. N. Vinogradova
Yu. N. Vinogradova
MTM. S. Tlostanova
M. S. Tlostanova
AIA. A. Ivanova
A. A. Ivanova
APA. Yu. Pakhomov
A. Yu. Pakhomov
NIN. V. Ilyin
N. V. Ilyin
Introduction: Metabolic Tumor Volume (MTV) and Total Tumor Lesion Glycolysis (TLG) are used in 18F-fluorodeoxyglucose Positron-Emission Tomography combined with Computed Tomography (18F-FDG PET/CT) as functional markers, indicating tracer uptake in whole tumor. MTV and TLG are not yet engaged in clinical practice, because volume measurement accuracy depends on the selected measurement method, and optimal MTV and TLG segmentation is not established.Purpose: Assessment of accuracy of metabolic tumor volume measurement ways, using 18F-FDG PET/CT in patients with Diffuse Large B-Cell Lymphoma (DLBCL).Material and methods: Baseline 18F-FDG PET/CT performed in 21 patients with DLBCL. Tumor Volume (TV), measured on contrast enhanced CT (CTTV), considered as reference. While measuring MTV, we aimed to achieve a 1:1 ratio between CTTV and MTV. If anatomical and metabolic tumor contours matched, MTV was considered true (MTVtrue). Overall MTV and TLG measurements are 254. Tumor contouring, using relative thresholds, was made around Standardized Uptake Value (SUVmax) of tracer in tumor and intact liver.Results: On CT, the size of the lesions varied from 24 to 241 mm, M = 103.4±62.3, Me = 93 (48.5–155.5). In 15 (71.4 %) foci, hypodense areas of necrosis were determined. PET imaging revealed high tracer uptake in all foci of varying degrees of intensity. SUVmax values in tumors ranged from 5.8 to 30.5, Me = 20.4 (17.3–23.2). No significant correlation was found between the size of the foci and SUVmax (ρ = 0.17, p = 0.4744). The best accuracy in measuring MTV was observed when several thresholds were applied: VOIPERCIST, VOI2.5, VOIauto-contour, as well as VOI10 %, VOI15 % and VOI20 %. The optimal absolute threshold values were SUV values in the range from 2 to 3, and relative values in the range from 10 % to 20 % of the SUVmax in the tumor. MTV underestimation was more often determined using relative cut-off indices in the range of25–50 % and SUV thresholds ≥ 5.3.Conclusion: The results obtained showed that the use of a single threshold value for MTV segmentation in patients with DLBCL is not advisable. The choice of the MTV measurement method should be carried out individually for each lesion, taking into account its shape, size and structure, as well as the intensity and uniformity of tracer uptake in the tumor and adjacent anatomical structures.

5 November 2025 in Voprosy onkologii
Verified
Journal Article
Open access
PDF file
АКАлексей Владимирович Козлов
Алексей Владимирович Козлов
PTPavel Gadelgaraevich Tarazov
Pavel Gadelgaraevich Tarazov
ЮВЮлия Николаевна Виноградова
Юлия Николаевна Виноградова
ДКДенис Сергеевич Колесников
Денис Сергеевич Колесников
АДАндрей Евгеньевич Демко
Андрей Евгеньевич Демко
ДГДмитрий Анатольевич Гранов
Дмитрий Анатольевич Гранов
Введение. В настоящее время роль регионарной химиотерапии (РХТ) и лучевой терапии (ЛТ) у больных раком поджелудочной железы окончательно не определена. Цель. Изучить ближайшие и отдаленные результаты комбинации РХТ и ЛТ по сравнению с выполнением панкреатодуоденальной резекции (ПДР) у больных РПЖ, имеющих высокий хирургический риск осложнений и летальности. Материалы и методы. Группу исследования составили 33 больных аденокарциномой головки поджелудочной железы со стадией Т2-3N0-1М0 IB-IIВ и III классом физического статуса по классификации ASA. На первом этапе была проведена РХТ в виде химиоэмболизации (ХЭ) головки поджелудочной железы с гемцитабином и липиодолом с последующей артериальной химиоинфузией гемцтабина и оксалиплатина (схема GEMOX). На втором этапе лечения выполнена ЛТ в режиме дневного дробления дозы (4 Гр в сут.) до суммарной очаговой дозы 50 Гр. В контрольную группу включены 36 больных с аналогичными стадиями заболевания и III классом ASA, которым выполнили ПДР в многопрофильной клинике. Результаты. Госпитальной летальности после химиолучевой терапии не было. Послеоперационная летальность отмечена в группе контроля у пяти (13,9 %) больных. Осложнения III-IV степени по классификации Clavien — Dindo были отмечены только после операции (n = 15, 41,7 %) (р < 0,05). Медиана времени до прогрессирования после химиолучевого лечения составила 7,8 (ДИ: 6,9–8,4) мес., после операции — 10,7 (95 % ДИ: 7,9-15,5) мес. (p < 0,05). Медианы общей и однолетней выживаемости составляли 12,4 (95 % ДИ: 10,5-17,8) мес. и 50 % против 17,4 (95 % ДИ: 11,6-25,5) мес. и 64 % соответственно (p < 0,05). В то же время общая выживаемость, оцениваемая по умершим больным (n = 26 vs n = 28), в обеих группах не различалась: 14,1 (95 % ДИ: 11,5-16,6) мес. и 14,5 (95 % ДИ: 10,5-18,5) мес. (p < 0,05). Выводы. Несмотря на высокую летальность и большое число осложнений, хирургическая операция обеспечивает лучшие показатели выживаемости даже у ослабленных больных. Актуальной является задача выявления неблагоприятных факторов для выполнения ПДР: у таких пациентов безопасной и относительно эффективной альтернативой может быть комбинация РХТ и ЛТ в режиме дневного дробления дозы.

31 December 2020 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
VPVsevolod G. Potapenko
Vsevolod G. Potapenko
IBIrena E. Belousova
Irena E. Belousova
JVJulia N. Vinogradova
Julia N. Vinogradova
KKKarina A. Kelehsaeva
Karina A. Kelehsaeva
AUAndrey M. Ulitin
Andrey M. Ulitin
ИВИльин Николай Васильевич
Ильин Николай Васильевич
RosaiDorfman disease (RDD) is a rare variant of the nonlangergans histiocytosis. Various presentation, systemic and localised forms and limited publications make diagnostics and prompt management difficult. Aim. Literature review and presentation of the patient with cutaneous form of RDD. Results. The patient is a 56 y.o male. In October 2019 he noticed a tumour in the left temporal area. After 3 weeks the tumor was removed. During the next two weeks the tumour recurred within the post-operative scar. After the review of the specimen and staging the skin form RosaiDorfman disease was diagnosed. Irradiation (total dose 36 Gr) was conducted. The tumor lessened. Through the next 4 months response is stable. Сonclusion. Radiation therapy as a second line of treatment of the skin RDD led to a stable response.

22 September 2025 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
MZMaria I. Zelianina
Maria I. Zelianina
JVJulia N. Vinogradova
Julia N. Vinogradova
DKDarya V. Kozlova
Darya V. Kozlova
DZDenis V. Zaslavsky
Denis V. Zaslavsky
NINikolay V. Ilyin
Nikolay V. Ilyin
ИВИльин Николай Васильевич
Ильин Николай Васильевич
Background: Timely diagnosis and assessment of radiation-induced skin reactions remain an important challenge in modern medicine. Imaging techniques can help standardize the clinical evaluation of radiation dermatitis. Aim: The work aimed to evaluate dermatoscopic features and confocal microscopy findings in radiation dermatitis among patients with primary cutaneous lymphomas undergoing radiotherapy, with subsequent analysis of the clinical and morphological characteristics of affected skin areas before treatment and at cumulative doses of 6 Gy, 14 Gy, and 30 Gy, based on macroscopic and dermatoscopic imaging of radiation-induced skin reactions for further comparison. Methods: Data from 40 patients at the Granov Russian Scientific Center for Radiology and Surgical Technologies receiving electron beam radiotherapy for primary cutaneous lymphomas were analyzed. As clinical symptoms of radiation-induced skin reactions developed, morphological changes in the affected areas were examined. Dermatoscopic evaluation of skin lesions was performed using a HYPERLINK "https://shop.heine-med.ru/catalog/dermatoskopy/?ysclid=m63jpoace3558532091"Heine Optotechnik (Germany) dermatoscope at tenfold magnification. Confocal spectroscopy was conducted using the VivaScope® 1500 medical device (MAVIG GmbH, Munich, Germany). Instrumental data underwent correlation analysis to identify statistical relationships between dermatoscopic parameters and the severity of radiation-induced skin reactions. Results: Dermatoscopy revealed patterns characteristic of different stages of radiation-induced skin reactions: reticular vascular arrangements in the dermis, brown scaly elements, perifollicular pigmentation, and follicular plugs arranged in rosette-like patterns. Confocal microscopy of radiation dermatitis lesions identified non-stochastic skin changes, including exocytosis (55.3%), spongiosis (63.5%), disorganization of the epidermis (65%), and abnormally structured dermal papillae (85.4%). Low-contrast microvascular cells marking vascular dysfunction in the dermal vascular bed were a specific feature of radiation dermatitis observed regardless of severity. Conclusion: Accurate assessment of skin damage severity can help optimize the management of patients undergoing radiotherapy for primary cutaneous lymphomas. These findings are promising for integrating instrumental evaluation methods into routine clinical practice for early detection of radiation-induced skin changes and predicting disease severity.